In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
 


The free consultation period for this content is over.

It is now only available year-round to ESC Professional Members, Fellows of the ESC, and Young combined Members

Case 2: Troponin elevation post noncardiac surgery

Session Myocardial injury versus myocardial infarction - Implications for clinical practice

Speaker Konstantin A Krychtiuk

Congress : ESC Congress 2018

  • Topic : coronary artery disease, acute coronary syndromes, acute cardiac care
  • Sub-topic : Acute Coronary Syndromes: Biomarkers
  • Session type : Case-based Session
  • FP Number : 4964

The free consultation period for this content is over.

It is now only available year-round to ESC Professional Members, Fellows of the ESC, and Young combined Members

Other presentations from this session

Myocardial injury versus myocardial infarction - Implications for clinical practice

  • ESC Congress 2018
  • Acute Coronary Syndromes - Clinical
  • Case-based Session
  • 28 August 2018
  • 08:30 - 10:00
session 2018 2018
8

Other presentations from this speaker

Konstantin A Krychtiuk speaker

Konstantin A Krychtiuk

Medical University of Vienna, Vienna (Austria)

21


Based on your interests

Three reasons why you should become a member

Become a member now
  • 1Access your congress resources all year-round on the New ESC 365
  • 2Get a discount on your next congress registration
  • 3Continue your professional development with free access to educational tools
Become a member now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are